Breaking News Bar

Business News and Information

The Daily Herald Market Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Teva Pharmaceutical Industries Ltd (NY: TEVA)
21.47 USD  +0.04 (+0.19%)
Streaming Delayed Price  /  Updated: 9:32 AM EDT, Oct 22, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 134,898
Open 21.51
Bid (Size) 21.47 (1)
Ask (Size) 21.48 (5)
Prev. Close 21.43
Today's Range 21.43 - 21.52
52wk Range 10.85 - 25.96
Shares Outstanding 1,018,482,488
Dividend Yield 5.54%
Performance
YTD
+12.35%
+12.35%
1 Month
-11.86%
-11.86%
3 Month
-7.38%
-7.38%
6 Month
+20.28%
+20.28%
1 Year
+47.66%
+47.66%
Top News
More News
New Research: Key Drivers of Growth for Teva Pharmaceutical Industries, Axovant Sciences, SolarEdge Technologies, NantHealth, Kosmos Energy, and Retrophin — Factors of Influence, Major Initiatives and
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Teva Pharmaceutical... Read More
from GlobeNewswire News Releases
Teva and New Jersey Governor Murphy Formalize North America Headquarters Move with Ceremony in Israel
Teva Pharmaceuticals announced that Teva executives Kåre Schultz and Brendan O’Grady, alongside State of New Jersey Governor, Phil Murphy, formalized Teva’s commitment to consolidate its North America... Read More
from Business Wire News Releases
More News
Read More
Stocks To Watch: Teva Pharmaceutical Sees RS Rating Rise To 84
from Investor's Business Daily
Regeneron's Drug Will Be Fifth In Asthma — But 'It Will Be The Best'
from Investor's Business Daily
Regeneron's Drug Will Be Fifth In Asthma — But 'It Will Be The Best'
from Investor's Business Daily
Noteworthy ETF Inflows: SPDW, PKX, TEVA, FLEX
category ETFs
from ETF Channel
Teva Pharmaceutical Clears Key Benchmark, Hitting 80-Plus RS Rating
from Investor's Business Daily
Better Buy: Biogen Inc. vs. Amgen Inc.
category TEVA , LLY , NVS , and 4 more.
from Motley Fool
Borrowing costs could rise for indebted US blue chip companies
category companyNews
from Reuters: Company News
UPDATE 1-Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva
category companyNews
from Reuters: Company News
Stocks making the biggest move premarket: NFLX, IBM, CSX, UAL, TEVA & more
category CSX Corp , Eli Lilly and Co , Teva Pharmaceutical Industries Ltd , and 16 more.
from CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account